Offerings // NewAmsterdam Pharma Co N.V.

NAMS offering history

Every offering-related filing in NewAmsterdam Pharma Co N.V.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 399 filings back to Aug 4, 2022.

Last executed offering
Dec 13, 2024
424B5 — priced deal (shares or notes)
Last registration (announced)
Feb 28, 2025
S-3 — capacity, not a sale
Executed, last 12 months
0
424B pricings + 8-K 3.02 sales
Registered, last 12 months
0
S-1/S-3/F-series registrations
DateFilingWhat it means
Mar 10, 2025424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 10, 2025EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Feb 28, 2025S-3REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Dec 13, 2024424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 11, 2024S-3MEFREGISTEREDS-3MEF registration — capacity to sell shares, not a sale yet
Dec 10, 2024424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 12, 2024EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Aug 9, 2024424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 12, 2024EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Jul 3, 2024S-3REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Apr 19, 2024424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Apr 17, 2024EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Mar 12, 2024424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 8, 2024EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Feb 15, 2024424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 13, 2024424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 19, 2023424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 19, 2023EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Dec 7, 2023F-3REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Nov 13, 2023424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 21, 2023424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Aug 15, 2023424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Aug 11, 2023EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Jun 21, 2023424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Jun 12, 2023424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Jun 8, 2023424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Jun 6, 2023424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
May 23, 2023424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
May 8, 2023424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Apr 25, 2023424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Apr 24, 2023EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Jan 31, 2023424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Jan 30, 2023EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Jan 17, 2023F-1/AREGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Dec 20, 2022F-1REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Oct 18, 2022424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Oct 18, 2022EFFECTEFFECTIVESEC declared a registration effective — selling can begin
NAMS offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full NAMS workspace →
NAMS offering FAQ

When did NAMS last execute an offering?

Per SEC filings, NewAmsterdam Pharma Co N.V.'s most recent priced offering document is a 424B5 filed 2024-12-13. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did NAMS last announce or register an offering?

The most recent registration is a S-3 filed 2025-02-28. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.